Literature DB >> 21983439

Design, synthesis, and SAR studies of novel polycyclic acids as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1).

Xiang-Yang Ye1, Stephanie Y Chen, Akbar Nayeem, Rajasree Golla, Ramakrishna Seethala, Mengmeng Wang, Timothy Harper, Bogdan G Sleczka, Yi-Xin Li, Bin He, Mark Kirby, David A Gordon, Jeffrey A Robl.   

Abstract

Starting from high throughput screening hit 2-adamantyl acetic acid 3, a series of polycyclic acids have been designed and synthesized as novel, potent, and selective inhibitors of human 11β-HSD-1. Structure-activity relationships of two different regions of the chemotype (polycyclic ring and substituents on quaternary carbon) are discussed.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21983439     DOI: 10.1016/j.bmcl.2011.09.055

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 Diabetes.

Authors:  Zhao-Kui Wan; Eva Chenail; Huan-Qiu Li; Manus Ipek; Jason Xiang; Vipin Suri; Seung Hahm; Joel Bard; Kristine Svenson; Xin Xu; Xianbin Tian; Mengmeng Wang; Xiangping Li; Christian E Johnson; Ariful Qadri; Darrell Panza; Mylene Perreault; Tarek S Mansour; James F Tobin; Eddine Saiah
Journal:  ACS Med Chem Lett       Date:  2012-11-23       Impact factor: 4.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.